# Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.

> **NCT07241247** · PHASE4 · COMPLETED · sponsor: **Tanta University** · enrollment: 44 (actual)

## Conditions studied

- Vitamin D on Tumor Response and Inflammatory Markers
- Colo-rectal Cancer

## Interventions

- **DRUG:** Vitamin D

## Key facts

- **NCT ID:** NCT07241247
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-31
- **Primary completion:** 2025-06-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07241247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07241247, "Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07241247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
